The Basics of Radiation Oncology

Opinion
Video

Radiation oncologists Nina Sanford, MD, and Jeffrey M. Ryckman, MD, provide an overview of treatment modalities, highlighting SRS, SBRT, proton therapy, and how options have improved.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Recent Videos
      Frontline Setting of Pancreatic Cancer
      Frontline Setting of Pancreatic Cancer
      Treatment Algorithm for Metastatic Pancreatic Cancer
      Treatment Algorithm for Metastatic Pancreatic Cancer
      Role of Radiation in Pancreatic Cancer Treatment
      Role of Radiation in Pancreatic Cancer Treatment
      NGS and Germline Testing in Pancreatic Cancer
      NGS and Germline Testing in Pancreatic Cancer
      Overview of Pancreatic Cancer Treatment Approach
      Overview of Pancreatic Cancer Treatment Approach
      Deciding Which RP to Utilize
      Deciding Which RP to Utilize
      Making Sense of PARP Inhibitors
      Making Sense of PARP Inhibitors
      Consideration for Other Androgen Receptor Inhibitors
      Consideration for Other Androgen Receptor Inhibitors
      Prostate Cancer in 2025
      Prostate Cancer in 2025
      3 experts in this video
      Sequencing Treatment for Endocrine-Resistant Disease
      Related Content
      Ten-fraction image-guided hypofractionated radiation therapy could be a feasible treatment option for portal vein tumor thrombosis in patients with HCC.

      Hypofractionated RT Shows Portal Vein Tumor Thrombosis Control, OS in HCC

      Roman Fabbricatore
      April 29th 2025
      Article

      Ten-fraction image-guided hypofractionated radiation therapy could be a feasible treatment option for portal vein tumor thrombosis in patients with HCC.

      Govindarajan Narayanan, MD, speaks to the potential time-saving advantages of using the Epione robot for microwave ablation, cryoablation, and other surgical strategies in patients with liver cancer and other tumors.

      Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery

      Govindarajan Narayanan, MD
      December 4th 2023
      Podcast

      Govindarajan Narayanan, MD, speaks to the potential time-saving advantages of using the Epione robot for microwave ablation, cryoablation, and other surgical strategies in patients with liver cancer and other tumors.

      MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.

      FDA Grants EvoLiver Biopsy Test Breakthrough Device Designation for HCC

      Roman Fabbricatore
      April 23rd 2025
      Article

      MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.

      FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

      FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

      Ariana Pelosci;Tim Cortese
      April 11th 2025
      Article

      Results from the phase 3 CheckMate 9DW trial of nivolumab/ipilimumab vs lenvatinib or sorafenib led to the approval for patients with unresectable or metastatic HCC.

      Most recently, the FDA accepted a second NDA for camrelizumab/rivoceranib as a treatment for patients with unresectable HCC in October 2024.

      FDA Issues Second Camrelizumab/Rivoceranib CRL in Hepatocellular Carcinoma

      Roman Fabbricatore;Russ Conroy
      March 21st 2025
      Article

      The complete response letter for camrelizumab/rivoceranib for patients with advanced HCC did not specify what deficiencies regulators found.

      FDA Grants Fast Track Designation to Amezalpat Combination in HCC

      FDA Grants Fast Track Designation to Amezalpat Combination in HCC

      Tim Cortese
      February 11th 2025
      Article

      Amezalpat plus atezolizumab and bevacizumab achieved a 6-month increase for OS compared with atezolizumab and bevacizumab alone in patients with HCC.